Clinical Trial Update: Abiraterone Acetate in Molecular Apocrine Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating abiraterone acetate in molecular apocrine breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED